Product Information
SEVELAMER HCL 800 MG TABLET is a generic product labeled by Macleods Pharmaceuticals Limited, priced at $0.7453 per EA under NDC 33342024257. Its NADAC has been published 104 times since Jul 3, 2024.
Strength
800 mg/1
Manufacturer
Macleods Pharmaceuticals LimitedNDC
33342024257
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
SEVELAMER HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA206883On Market Since
5/26/2023
Pharmacological Classes
Price Statistics
The NADAC for SEVELAMER HCL 800 MG TABLET has been published 104 times since Jul 3, 2024, and over the history we have for it it has declined 42.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.7453 per EA |
|---|---|
| All-time high | $1.5808 (Sep 11, 2024) |
| All-time low | $0.7453 (Jun 17, 2026) |
| 52-week high | $1.3679 |
| 52-week low | $0.7453 |
| Median price | $1.2784 |
| Average price | $1.2153 |
| Largest weekly change | +18.2% (Jul 17, 2024) |
| Weeks tracked | 104 |
| Tracking since | Jul 3, 2024 |
Generic Alternatives
The matcher finds 3 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 3 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of SEVELAMER HCL 800 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for SEVELAMER HCL 800 MG TABLET, manufactured by Macleods Pharmaceuticals Limited, is $0.7453 per EA (NDC 33342024257), effective Jun 24, 2026.
How has the price of SEVELAMER HCL 800 MG TABLET changed over time?
Over the history we have for it, the NADAC for SEVELAMER HCL 800 MG TABLET has declined 42.1%. It has been tracked across 104 weekly CMS publications since Jul 3, 2024.
What are the highest and lowest recorded NADAC prices for SEVELAMER HCL 800 MG TABLET?
Since Jul 3, 2024, the NADAC for SEVELAMER HCL 800 MG TABLET has ranged from a low of $0.7453 (Jun 17, 2026) to a high of $1.5808 (Sep 11, 2024), with a median of $1.2784 per EA.
Are there cheaper alternatives to SEVELAMER HCL 800 MG TABLET?
3 NADAC-published products share the same active ingredient, strength, and dosage form as SEVELAMER HCL 800 MG TABLET, but none are currently priced below it.
Who manufactures SEVELAMER HCL 800 MG TABLET?
SEVELAMER HCL 800 MG TABLET (NDC 33342024257) is labeled by Macleods Pharmaceuticals Limited, and CMS classifies it as a generic product.
Related Drugs
Same classification